IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 6418 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded214    
    Comments [Add]    

Recommend this journal


Year : 2000  |  Volume : 32  |  Issue : 3  |  Page : 221-225

Effect of Trichopus zeylanicus gaertn (active fraction) on phagocytosis by peritoneal macrophages and humoral immune response in mice

Correspondence Address:
A Subramoniam

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Objectives: To evaluate whether Trichopus zeylanicus (active fraction) influences (1) phagocytosis by mice peritoneal macrophages (2) antibody dependent complement mediated cytotoxicity to Ehrlichs ascitic carcinoma (EAC) cells and (3) humoral antibody response in mice. Methods: Phagocytosis of opsonized sheep RBC by peritoneal macrophages obtained from control or T. zeylanicus (active fraction) treated (10-40 mg/kg, daily, p.o., 5 days) mice was determined. The in vitro effect of the drug on macrophage phagocytosis was also studied. The effect of the drug on antibody dependent and complement mediated toxicity (ACC) to EAC cells was carried out using antiserum obtained from drug treated ( p.o., daily for 5 days) mice which were challenged with or without EAC cells. The effect of the drug on humoral immune response in mice was studied by measuring haemagglutination antibody titre and Jerne's plaque forming assay using sheep RBC as antigens. Results: The drug treatment to mice resulted in stimulation of phagocytosis by peritoneal macrophages; but in vitro treatment to macrophages did not influence their phagocytic efficacy. The drug treatment enhanced ACC, haemagglutinating antibody titre and the number of antibody producing spleen cells in mice. Conclusion: The drug stimulates macrophage phagocytosis in mice; but not under in vitro conditions. The drug also enhances ACC mediated cancer cell killing and humoral antibody response in mice.


Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow